Literature DB >> 15084562

Evidence for association between hepatitis C virus seropositivity and coronary artery disease.

C Vassalle, S Masini, F Bianchi, G C Zucchelli.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15084562      PMCID： PMC1768206          DOI： 10.1136/hrt.2003.018937

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither?

Authors:  P K Shah
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

2.  Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Eiko Takahashi; Ei ichi Tooda; Hideki Hashimoto; Ryozo Nagai; Minoru Yamakado
Journal:  Lancet       Date:  2002-01-12       Impact factor: 79.321

3.  Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study.

Authors:  S Kiechl; G Egger; M Mayr; C J Wiedermann; E Bonora; F Oberhollenzer; M Muggeo; Q Xu; G Wick; W Poewe; J Willeit
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

4.  Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease.

Authors:  Cristina Vassalle; Nicoletta Botto; Maria Grazia Andreassi; Sergio Berti; Andrea Biagini
Journal:  Coron Artery Dis       Date:  2003-05       Impact factor: 1.439

5.  Evidence for a monoclonal origin of human atherosclerotic plaques.

Authors:  E P Benditt; J M Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205
  5 in total
  49 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

2.  Viral hepatitis: Drug-drug interactions in HCV treatment--the good, the bad and the ugly.

Authors:  Jacob A Langness; Gregory T Everson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-17       Impact factor: 46.802

3.  The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.

Authors:  Parag Mahale; Eric A Engels; Ruosha Li; Harrys A Torres; Lu-Yu Hwang; Eric L Brown; Jennifer R Kramer
Journal:  Gut       Date:  2017-06-20       Impact factor: 23.059

Review 4.  Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.

Authors:  Susanna Naggie
Journal:  Top Antivir Med       Date:  2017 Feb/Mar

Review 5.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 6.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

7.  Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Authors:  Elizabeth M Kiefer; Qiuhu Shi; Donald R Hoover; Robert Kaplan; Russell Tracy; Michael Augenbraun; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Mardge Cohen; Elizabeth T Golub; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.

Authors:  Anne M Guiltinan; Zhanna Kaidarova; Brian Custer; Jennie Orland; Angela Strollo; Sherri Cyrus; Michael P Busch; Edward L Murphy
Journal:  Am J Epidemiol       Date:  2008-01-17       Impact factor: 4.897

9.  Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.

Authors:  Jason Reingold; Christine Wanke; Donald Kotler; Cora Lewis; Russell Tracy; Steven Heymsfield; Phyllis Tien; Peter Bacchetti; Rebecca Scherzer; Carl Grunfeld; Michael Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

Review 10.  Dysmetabolic changes associated with HCV: a distinct syndrome?

Authors:  Amedeo Lonardo; Paola Loria; Nicola Carulli
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.